Trial Profile
Effect of Dapagliflozin on the Blood Pressure Variability and the Ambulatory Arterial Stiffness Index in Individuals With Stage I Hypertension Without Diabetes Mellitus
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 04 Aug 2022
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 23 Dec 2020 Planned End Date changed from 1 Dec 2020 to 1 Jul 2021.
- 23 Dec 2020 Planned primary completion date changed from 1 Nov 2020 to 1 Apr 2021.
- 12 Apr 2020 Planned End Date changed from 9 Dec 2020 to 1 Dec 2020.